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WHAT THIS PAPER ADDS
 Multiple randomised trials have demonstrated lower perioperative mortality after endovascular aneurysm repair (EVAR) compared
to open surgical repair (OSR) for infrarenal abdominal aortic aneurysms (AAAs). The median age of the patients in these trials was
more than 70 years. We compared EVAR (n ¼ 369) and OSR (n ¼ 282) in patients younger than 60 years of age in terms of 30-day
mortality (EVAR ¼ 1.1%; OSR ¼ 0.4%; P ¼ 0.22) using the National Surgical Quality Improvement Program (NSQIP) data set. These
contemporary results demonstrate similar peri-procedural mortality rate after OSR and EVAR in patients younger than 60 years of
age. Our data can aid in the informed consent process of younger patients with AAA. All patients should be educated about the
advantages and disadvantages of EVAR; some would prefer the upfront morbidity risk of open surgery to avoid the late conse-
quences of EVAR, while others would not.a r t i c l e i n f o
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Objectives: Multiple randomised trials have demonstrated lower perioperative mortality after endovas-
cular aneurysm repair (EVAR) compared to open surgical repair for infrarenal abdominal aortic aneu-
rysms (AAAs). However, in these trials the mortality advantage for EVAR is being lost within 2 years of
repair and the patients evaluated are relatively older with no study speciﬁcally comparing EVAR and
open repair for patients younger than 60 years of age.
Design: A retrospective analysis of prospectively collected data.
Materials and methods: Patients younger than 60 years of age who underwent EVAR and open surgical
repair for elective infrarenal AAA were identiﬁed from the 2007e09 National Surgical Quality
Improvement Program (NSQIP) e a prospective database maintained at 237 centres across the United
States. Univariate and multivariate analyses were performed.
Results: Of the 651 patients, 369 (56.7%) underwent EVAR and 282 (43.3%) underwent open repair.
Thirty-day mortality for EVAR and open repair were 1.1% and 0.4%, respectively. This was not signiﬁcantly
different on univariate (P ¼ 0.22) as well as multivariate (P ¼ 0.69) analysis after controlling for other
co-morbidities. On multivariate analysis, body mass index, history of stroke and bleeding disorder prior
to surgery were associated with a higher 30-day mortality after AAA repair (combined open and EVAR).
Conclusions: These contemporary results demonstrate that the 30-day mortality rate after open repair is
similar to that after EVAR in patients younger than 60 years with infrarenal AAA.
Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.stions on this paper, please go to www.vasculareducation.com and click on ‘CME’
, 15 September 2011 at Chicago, IL, USA.
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ar and Endovascular Surgery 43 (2012) 506e512 507Parodi’s landmark paper in 1991 on endovascular aneurysm
repair (EVAR) marked a paradigm shift in abdominal aortic aneu-
disagreements were at 1.60% (>140,000 audited ﬁelds).14 The
processes of SCR training, inter-rater reliability auditing, dataP.K. Gupta et al. / European Journal of Vasculrysm (AAA) repair.1 Since then, multiple randomised prospective
multicentre trials have demonstrated lower perioperativemortality
after EVAR compared to open infrarenal AAA repair.2e4 These
ﬁndings have been further corroborated in population-based
studies.5 The immediate perioperative advantages of the endovas-
cular approach are, however, lost with time. Follow-up data from
the randomised trials have shown equivalent mortality after open
and endovascular approaches by 2 years, with the merging of the
mortality curves related to late deaths in the EVAR cohort.3,6e8
EVAR has also been shown to have a signiﬁcantly higher re-
intervention rate.6,8 Further, graft-related complications after
EVAR necessitate multiple routine follow-up computed tomo-
graphic scans with the associated radiation exposure, which could
be an issue for the younger patients.
The trials and population studies demonstrating lower per-
ioperative mortality after EVAR compared to open AAA repair
had patients with a median age over 70 years. Due to their
relatively advanced age, these patients would be at a higher
perioperative risk after open surgery compared to the less
invasive EVAR.9e11 Previous studies have not compared EVAR to
open AAA repair in relatively younger patients. We hypoth-
esised that in patients younger than 60 years in age, peri-
operative outcomes after open surgical repair would not be
inferior to EVAR. Further, given the higher mortality rates
associated with EVAR beyond the perioperative period,6,8 open
repair may be associated with a lower overall mortality in
comparison to EVAR. We used the multicentre (237 hospitals as
of 2009), prospective, National Surgical Quality Improvement
Program (NSQIP) data sets to compare 30-day outcomes after
open and endovascular elective infrarenal aortic aneurysm
repair in patients younger than 60 years.Materials and Methods
Data set
Data were extracted from the 2007, 2008 and 2009 American
College of Surgeons NSQIP Participant Use Data Files.12 These are
multicentre, prospective databases with 183 (year 2007), 211 (year
2008) and 237 (year 2009) participating academic and community
US hospitals, with data being collected on 136 perioperative vari-
ables. NSQIP is a risk-adjusted data collection mechanism that
collects and analyses clinical outcomes data. Participating hospitals
use their collected data to develop quality initiatives that improve
surgical care, with participation being voluntary. In NSQIP,
a participating hospital’s surgical clinical reviewer (SCR) captures
data through 30 days following surgery using a variety of methods,
one of which is medical chart abstraction. Events occurring after
hospital discharge were identiﬁed using comprehensive strate-
gies.13 In addition to examining inpatient medical records and
outpatient patient charts, a minimum of three attempts to contact
the patient by telephone or mail are made to ensure accurate
documentation of post-discharge events. If no response is obtained,
the Social Security Death Index and the National Obituary Archives
are queried to investigate the potential of a death. Hospitals are
required to provide complete 30-day follow-up on at least 95% of
patients.13
The data are collected based on strict criteria formulated by
a committee. To ensure that the data collected are of a high quality,
the NSQIP has developed different training mechanisms for the SCR
and conducts an inter-rater reliability audit of participating sites.12
Inter-rater reliability audits revealed that in 2008 totalcollection and sampling methodology have been previously
described in detail.12Patients
Patients younger than 60 years of age undergoing elective open
and endovascular repair of infrarenal AAAs were identiﬁed from
the NSQIP data sets. Preoperative data obtained included demo-
graphics, lifestyle, co-morbidity and other variables (Table 1).
Complete deﬁnitions for all the above-listed variables have been
previously published elsewhere.12Outcome
The primary outcome of interest was 30-day mortality. Other
outcomes analysed included hospital length of stay, minor
morbidity (urinary tract infection or superﬁcial wound infection)
and major morbidity. The latter included deep wound infection,
organ space infection, wound dehiscence, pneumonia, reintuba-
tion, on ventilator >48 h, pulmonary embolus, deep venous
thrombosis, renal insufﬁciency, acute renal failure, stroke, coma,
peripheral nerve deﬁciency, graft/prosthesis failure, cardiac arrest,
myocardial infarction, transfusion >4 units packed red blood cells
(PRBCs) within 72 h, sepsis, and septic shock or return to the
operating room. The NSQIP database captures outcomes through 30
days following surgery, except for hospital length of stay, which is
recorded till the patient is discharged.
Sepsis has been deﬁned in NSQIP as systemic inﬂammatory
response syndrome (SIRS) along with a positive blood culture or
clinical documentation of purulence or positive culture from any
site thought to be causative. SIRS is clinically recognised by the
presence of two or more of the following within 48 h prior to
surgery: temperature >38 C or <36 C; heart rate >90; respira-
tory rate >20 breaths/min or partial pressure of carbon dioxide in
arterial blood (PaCO2) <32 mmHg (<4.3 kPa); white blood cell
count >12,000 cells mm3, <4000 cells mm3, or >10% immature
(band) forms; anion gap acidosis deﬁned as [Na þ K]  [CL þ HCO3
(or serum) CO2] > 16 or Na  [CL þ HCO3 (or serum) CO2] > 12.
Reintubation was said to have occurred if a patient was intubated
postoperatively once extubated. If the patient returned to the
operating room for any reason and was intubated as part of the
anaesthesia/surgery, then it was not counted as a reintubation. If
a patient self-extubated and had to be reintubated, then also it
was not counted as a reintubation. Complete deﬁnitions for all the
other above-listed variables have been previously published
elsewhere.12Statistical analysis
Univariate exploratory analysis was performed using Pearson
chi-square test or Fisher’s exact test for categorical variables and
t- or F-test for continuous variables. Stepwise multivariate
logistic regression was performed to assess risk factors for per-
ioperative morbidity and mortality. Type of aortic repair (open
vs. endovascular) was forced into the logistic regression analysis.
Both the C-statistic and the P-value for the HosmereLemeshow
goodness of ﬁt test were obtained to determine if there was
a satisfactory ﬁt of the model. All statistical analyses were per-
formed using Statistical Analysis System (SAS, version 9.2; SAS
Institute, Cary, NC, USA). P-value <0.05 was considered as
signiﬁcant.
Table 1
Preoperative and intraoperative characteristics.
Category Preoperative/Intraoperative variable Open repair EVAR P-value
N (%)
Total 282 (100) 369 (100)
Cardiac Angina within 1 month Yes 3 (1.1) 10 (2.7) 0.14
Cardiac surgery prior Yes 39 (13.8) 62 (16.8) 0.30
Congestive heart failure Yes 2 (0.7) 7 (1.9) 0.20
Myocardial infarction (within 6 months) Yes 3 (1.1) 4 (1.1) 0.98
Percutaneous coronary intervention prior Yes 57 (20.2) 92 (24.9) 0.16
Circulatory Bleeding disorder Yes 20 (7.1) 39 (10.6) 0.13
PAD Yes 21 (7.5) 20 (5.4) 0.29
Rest pain in lower extremity Yes 7 (2.5) 6 (1.6) 0.44
Wound (Open) Yes 4 (1.4) 6 (1.6) 0.83
General Age (Median) in years (Inter-quartile range) 56 (53e58) 56 (54e58) 0.004
ASA Class 1 14 (5.0) 12 (3.3) 0.33
2 74 (26.3) 118 (32.0)
3 155 (55.2) 190 (51.5)
4 37 (13.2) 49 (13.3)
5 1 (0.4) 0
BMI (Median) in kg/m2 (Inter-quartile range) 29.0 (25.7e33.3) 30.0 (26.0e33.9) 0.049
Corticosteroid use (chronic) Yes 3 (1.1) 18 (4.9) 0.006
Diabetes mellitus On insulin 22 (7.8) 20 (5.4) 0.41
On medication 16 (5.7) 18 (4.9)
Functional status Partially dependent 9 (3.2) 7 (1.9) 0.41
Totally dependent 2 (0.7) 1 (0.3)
Hypertension Yes 215 (76.2) 280 (75.9) 0.92
Prior operation within 30 days Yes 4 (1.4) 5 (1.4) 0.95
Race American Indian 1 (0.4) 2 (0.5) 0.41
Asian/Paciﬁc Islander 1 (0.4) 2 (0.5)
Black 21 (7.5) 29 (7.9)
Hispanic 9 (3.2) 5 (1.4)
Unknown 15 (5.3) 31 (8.4)
White 235 (83.3) 300 (81.3)
Sex Male 227 (80.5) 335 (90.8) 0.0002
Female 55 (19.5) 34 (9.2)
Transition (admitted from) Home 273 (96.8) 359 (97.3) 0.37
Acute care 8 (2.8) 8 (2.2)
Chronic care 1 (0.4) 0
Others 0 2 (0.5)
Weight loss > 10% within 6 months Yes 4 (1.4) 12 (3.3) 0.13
Laboratory Albumin Abnormal 21 (7.5) 33 (8.9) 0.60
Normal 123 (43.6) 148 (40.1)
Unknown 138 (48.9) 188 (51.0)
Creatinine Abnormal 23 (8.2) 33 (8.9) 0.94
Normal 251 (89.0) 326 (88.4)
Unknown 8 (2.8) 10 (2.7)
Haematocrit Abnormal 43 (15.3) 46 (12.5) 0.16
Normal 234 (83.0) 308 (83.5)
Unknown 5 (1.8) 15 (4.1)
Platelets Abnormal 40 (14.2) 64 (17.3) 0.23
Normal 236 (83.7) 291 (78.9)
Unknown 6 (2.1) 14 (3.8)
Prothrombin time Abnormal 61 (21.6) 76 (20.6) 0.93
Normal 137 (48.6) 179 (48.5)
Unknown 84 (29.8) 114 (30.9)
Partial thromboplastin time Abnormal 27 (9.6) 36 (9.8) 0.99
Normal 167 (59.2) 219 (59.4)
Unknown 88 (31.2) 114 (30.9)
White blood cell count Abnormal 41 (14.5) 45 (12.2) 0.28
Normal 235 (83.3) 309 (83.7)
Unknown 6 (2.1) 15 (14.1)
Neurologic Hemiplegia Yes 3 (1.1) 3 (0.8) 0.74
Stroke with neurologic deﬁcit Yes 8 (2.8) 10 (2.7) 0.92
Stroke without neurologic deﬁcit Yes 7 (2.5) 11 (3.0) 0.71
Transient ischaemic attack Yes 8 (2.8) 19 (5.2) 0.14
Renal On dialysis preoperatively Yes 1 (0.4) 11 (3.0) 0.01
Respiratory Chronic obstructive pulmonary disease Yes 37 (13.1) 59 (16.0) 0.31
Dyspnoea At rest 1 (0.4) 7 (1.9) 0.07
On moderate exertion 52 (18.4) 84 (22.8)
Social Alcohol intake within last 2 weeks Yes 23 (8.2) 32 (8.7) 0.81
Smoking within past year Yes 202 (71.6) 231 (62.6) 0.02
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Table 1 (continued )
Category Preoperative/Intraoperative variable Open repair EVAR P-value
N (%)
Total 282 (100) 369 (100)
Intraoperative Bifurcated graft Yes 141 (50.0) 321 (87.0) <0.0001
Intraoperative PRBC transfusion
in units (median)
1 0 <0.0001
Type of anaesthesia Regional 3 (1.1) 49 (13.3) <0.0001
General 279 (98.9) 320 (86.7)
Anaesthesia time in minutes (median) 317 198 <0.0001
Operative time in minutes (median) 226 129 <0.0001
EVAR e Endovascular aortic repair; ASA e American Society of Anesthesiologists; BMI e Body mass index; PAD e Peripheral arterial disease with history of previous
amputation/revascularization; PRBC e Packed red blood cells.
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Demographics, co-morbidities and therapy characteristics
A total of 10,251 patients underwent AAA repair in the 2007e09
NSQIP data. Of these, 651 patients (the study population) were
under 60 years of age. Two-hundred and eighty-two of these
patients underwent open aortic repair, while 369 patients under-
went EVAR. Median age was 56 years for both the open and EVAR
group of patients. Patients undergoing EVAR were more commonly
males (90.8% vs. 80.5%; P¼ 0.0002) and dialysis dependent (3.0% vs.
0.4%; P ¼ 0.01). There were no differences between the two groups
in terms of ASA class, diabetes, functional status, respiratory,
cardiovascular and neurologic co-morbidities (Table 1). Fifty
percent of the open repairs were ‘tube grafts’. Bifurcated prosthesis
was used for the majority of the EVARs (87.0%), while an aorto-
aortic tube prosthesis was used in 10.6% of cases and an aortou-
niiliac or aortounifemoral prosthesis was used in 2.4% of the cases.Outcomes
The 30-day mortality rate after open aortic repair was 0.4%
(n ¼ 1), while it was 1.1% (n ¼ 4) after EVAR. This was not signiﬁ-
cantly different on univariate (P ¼ 0.22) as well as multivariate
(P ¼ 0.69) analyses after controlling for other co-morbidities
(Table 2).
The data demonstrate that the single patient who died after
open repair required a return to the operating room where he
apparently died due to unknown causes on postoperative day
(POD) 1. Of the four patients who died after EVAR, the ﬁrst died on
POD 14 due to development of pneumonia and septic shock. The
patient had required a return to the operating room and had
developed postoperative renal failure and failure to wean from
ventilator within 48 h of surgery. The second patient died on POD
14, probably due to renal and respiratory failure. This second
patient had also required a return to the operating room and
developed postoperative renal failure and failure to wean from
ventilator within 48 h of surgery. The third patient died on POD 15,
due to postoperative septic shock after requiring a return to theTable 2
Variables associated with postoperative mortality in the stepwise logistic regression
analysis.
Parameter Adjusted
ODDS ratio
95% Wald
conﬁdence interval
Open vs. endovascular aortic repair 0.62 0.06e6.72
Body mass index per kg/m2 of increase 1.18 1.05e1.33
History of stroke with neurologic deﬁcit 37.04 2.24e500.0
Bleeding disorder prior to surgery 15.87 1.68e142.86
C-statistic e 0.83.operating room, reintubation and cardiac arrest. The last patient
died on POD 15 from postoperative septic shock after requiring
reintubation.
Body mass index (BMI), stroke with neurological disorder and
bleeding disorder were signiﬁcantly associated with 30-day
mortality on both univariate and multivariate analyses (Table 2).
Rest pain in lower extremities, open wound, American Society of
Anesthesiologists’ (ASA) class,15 abnormal creatinine and abnormal
platelets were signiﬁcant (P < 0.05) on univariate but not on
multivariate analysis.
The 30-day major morbidity rates were 18.8% (n ¼ 53) and 9.2%
(n ¼ 34) for open aortic repair and EVAR, respectively. This was
signiﬁcantly different on both univariate (P ¼ 0.0004) and multi-
variate (odds ratio 2.74; 95% conﬁdence interval: 1.66e4.50;
P < 0.0001) analyses (Table 3). COPD, hypertension, smoking
within 1 year of surgery andweight loss>10% prior to surgerywere
also signiﬁcantly associated with 30-day morbidity on both
univariate and multivariate analyses (Table 3). Site of attachment
(‘tube’ vs. bifurcated repair), female gender, BMI, dependent func-
tional status, congestive heart failure (CHF), open wound, anaes-
thesia time and operative time were signiﬁcant (P < 0.05) on
univariate but not on multivariate analysis.
Among major morbidities, signiﬁcantly higher rates of post-
operative sepsis, deep wound infection, greater than 4 units red
blood cell transfusion, renal insufﬁciency, reintubation and failure
towean fromventilator within 48 h of surgerywere seen after open
repair (P < 0.05; see Table 4). The median (lower quartileeupper
quartile) lengths of stay after open repair and EVAR were 6 (5e8)
and 2 (1e3) days, respectively (P < 0.0001).
Discussion
Currently in the United States, 60% of the aortic aneurysms are
repaired by endovascular techniques, and this number is increasing
every year.16 The widespread use of the endovascular approach is
largelydue to its decreasedperioperativemorbidity andmortality in
comparison to open repair. The Comparison of Endovascular Aneu-
rysm Repair with Open Repair in Patients with Abdominal AorticTable 3
Variables associated with postoperative morbidity in the stepwise logistic regres-
sion analysis.
Parameter Adjusted
ODDS ratio
95% Wald
conﬁdence interval
Open vs. endovascular aortic repair 2.74 1.66e4.50
Chronic obstructive pulmonary disease 2.36 1.34e4.17
Hypertension 2.84 1.39e5.82
Smoking within 1 year of surgery 1.96 1.11e3.45
Weight loss >10% within
six months of surgery
4.93 1.63e14.71
C-statistic e 0.73.
Table 4
Postoperative characteristics.
Postoperative variables Open repair EVAR P-value
N (%)
Total 282 (100) 369 (100)
Major Complications
Cardiac Cardiac arrest 1 (0.4) 1 (0.3) 0.85
Myocardial infarction 3 (1.1) 2 (0.5) 0.45
Circulatory Postoperative PRBC transfusion > 4 Units 3 (1.1) 0 0.047
Graft Graft/prosthesis failure 3 (1.1) 7 (1.9) 0.39
Infection Organ space infection 2 (0.7) 0 0.11
Sepsis 10 (3.6) 3 (0.8) 0.01
Septic shock 3 (1.1) 3 (0.8) 0.74
Neurologic Coma 0 0 e
Nerve deﬁcit 1 (0.4) 0 0.25
Stroke 1 (0.4) 1 (0.3) 0.85
Renal Acute renal failure 4 (1.4) 3 (0.8) 0.46
Renal insufﬁciency 3 (1.1) 0 0.047
Respiratory Pneumonia 8 (2.8) 5 (1.4) 0.18
Reintubation 12 (4.5) 5 (1.4) 0.02
Ventilator > 48 h 15 (5.3) 6 (1.6) 0.01
Return to operating room Return to operating room 22 (7.8) 21 (5.7) 0.28
Venous thromboembolism Deep venous thrombosis 4 (1.4) 2 (0.5) 0.25
Pulmonary embolism 2 (0.7) 0 0.11
Wound Deep wound infection 3 (1.1) 0 0.047
Wound dehiscence 6 (2.1) 2 (0.5) 0.07
Any major morbidity 53 (18.8) 34 (9.2) 0.0004
Minor Complications
Superﬁcial wound infection 7 (2.5) 6 (1.6) 0.44
Urinary tract infection 7 (2.5) 5 (1.4) 0.29
Other Postoperative Parameters
Number of days from operation to death, median (lower quartileeupper quartile) 1 (1e1) 14.5 (14e15) 0.0002
Length of stay in days, median (lower quartileeupper quartile) 6 (5e8) 2 (1e3) <0.0001
Mortality 1 (0.4) 4 (1.1) 0.22
EVAR e Endovascular aortic repair; PRBC e packed red blood cells.
Graft/prosthesis failure e Mechanical failure of an extracardiac graft or prosthesis including myocutaneous ﬂaps and skin grafts requiring return to the operating room,
interventional radiology, or a balloon angioplasty within 30 days of the operation.
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Management (DREAM) and the Veterans Affairs Open versus
Endovascular Repair (OVER) trials showed signiﬁcantly better 30-
day mortality after EVAR.2e4 The DREAM trial showed better 30-
day morbidity after EVAR; the OVER trial did not study 30-day
morbidity, but showed similar 1-year morbidity, while the EVAR 1
trial also did not speciﬁcally study 30-day morbidity. Recently
published, long-term data from these trials, show that over time the
mortality beneﬁt disappears, with patients having equivalent long-
term survival with both interventions.6,8 The mortality curves
merged in the ﬁrst year in the DREAM trial,7 between the ﬁrst and
second years in the EVAR 1 trial,17 and at 2 years in the OVER trial.3
The long-term data also showed that the rates of graft-related
complications and reinterventions were signiﬁcantly higher with
EVAR. Furthermore, the ACE (Anevrysme de l’aorte abdominale:
Chirurgie versus Endoprothese) trial published last year, comparing
open repair and EVAR in low- to moderate-risk patients (categories
0e2 according to the co-morbidity score of the Society for Vascular
Surgery/American Association for Vascular Surgery) showed no
difference between the two groups with respect to 30-day or 3 year
morbidity and mortality.18 In the EVAR group, however, reinter-
vention was signiﬁcantly higher, with a trend towards a higher
aneurysm-related mortality.
The results of the ACE trial suggest that the superior perioper-
ative outcomes seen after EVAR compared to open repair in the
DREAM, EVAR 1 and OVER trials are probably related to patient co-
morbidities and associated risk for open surgery. The OVER trial
used the RAND surgical risk score, with only 53% patients cat-
egorised as low risk for surgery. Patients in EVAR 1 or DREAM trial
may have been at a higher risk for open repair because riskassessment was left to the individual centre’s evaluation. In the ACE
trial, by restricting the patients to those with low and medium risk
based on the Society of Vascular Surgery co-morbidity score, the
perioperative advantage of EVAR over open repair was lost.
In the present study, 30-day mortality rates for open repair and
EVAR in patients under 60 years of age were 0.4% and 1.1%,
respectively. These rates are comparable to those from the ACE trial
(0.6% and 1.3%). The 30-day mortality rates for open repair in the
EVAR 1 trial, DREAM trial and OVER trial (3.0e4.6%) were higher
than those seen in the present study, while the mortality rates for
endovascular repair were similar (0.5e1.6%). The difference after
open repair seen in the present study compared to the EVAR 1,
DREAM and OVER trials is probably due to the lower age in the
NSQIP data with associated decrease in co-morbidities, as the
median age of patients in the DREAM, EVAR 1 and OVER trials was
around 70 years. Age has been previously shown to be associated
with higher perioperative mortality, especially after an abdominal
incision.9e11 The congruity in 30-day outcomes between our data
and those from the ACE trial suggests a possible similarity in the
overall risk proﬁles of the participants in the two studies. Both sets
of patients were low to moderate risk e based on age in our study
and Society of Vascular Surgery co-morbidity score in the ACE trial.
Females have been previously reported to have a higher risk for
complications after AAA repair.19,20 In the cohort of patients we
studied (less than 60 years old undergoing AAA repair) we did not
ﬁnd female gender to be signiﬁcantly associated with 30-day
mortality or morbidity on multivariate regression analysis.
In the present study, open repair was associated with a higher
risk for postoperative major morbidity. With further analysis of the
complications, the differences appear to be in postoperative sepsis,
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ciency (but not renal failure), reintubation and failure to wean from
ventilator within 48 h of surgery. Long-term data from the EVAR 1
and DREAM trials show a higher morbidity for the EVAR group due
to aneurysm-related complications and reinterventions.6,8 Medi-
care data, on the other hand, showed similar morbidity between
open repair and EVAR in the community due to laparotomy-related
complications after open surgery.5 There is no long-termmorbidity
data published speciﬁcally for patients less than 60 years of age
who undergo AAA repair. It is possible that due to the relatively
longer life span of these patients, they would be at a higher risk for
endograft-related complication after EVAR, as well as for
laparotomy-related complications after open repair.
Another source of potential morbidity that is not captured in
reports of 30-day, and long-term morbidity following EVAR, is
radiation exposure. Due to persistence of aneurysm-related
morbidities including rupture, in most centres, patients undergo
annual surveillance computed tomographic (CT) scans following
EVAR.21 An EVAR programme comprising planning CT, EVAR and
surveillance CT at 1, 6 and 12 months, and annually thereafter,
equates to a total effective radiation dose of around 145e205 mSv
over 5 years, with a single standard post-EVAR surveillance CT
angiogram exposing patients to a radiation dose of 20e30 mSv.21
These numbers are striking when contrasted to the cohort of
survivors from the 1945 atomic bombing where themean radiation
exposurewas 40mSv.22 Exposures to doses between 5 and 125mSv
(mean 34 mSv) were associated with a signiﬁcant increase in solid
cancer mortality. A 50-year-old exposed to 200 mSv has a lifetime
attributable cancer risk of 1.03% (1 in 100).21 Similarly, a large-scale
study of 400 000 radiation workers in the nuclear industry
(exposed to 20 mSv) also showed a signiﬁcant association
between radiation dose and mortality from cancer.22 Radiation is
a risk factor for developing cancer after a latency period of
between 10 and 20 years which is of particular concern for
patients under 60 which constitute the study cohort in this
report.23 Few studies have assessed duplex ultrasound imaging as
an alternative post-EVAR surveillance modality.24 Systematic
reviews of literature have shown colour duplex ultrasound to have
a lower sensitivity (<70%) for endoleak detection, thus making it
much less accurate than CT angiogram.25 Contrast-enhanced
ultrasound has a relatively higher sensitivity (77%) and holds
promise;26 however, till its use becomes widespread, CT angio-
gram remains the gold standard. The radiation risks associated
with surveillance CTs following EVAR must be carefully explained
to patients to enable a true informed consent.
Our study has several limitations. Variables analysed were
limited to those recorded by NSQIP. Despite the data set being fairly
comprehensive with more than 50 preoperative variables analysed,
information on preoperative stress test, echocardiography,
arrhythmia, electrocardiogram and glomerular ﬁltration rate was
not available. Anatomic data such as aneurysm diameter and rate of
growth, the presence of symptoms, reason for return to the oper-
ating room and data on hospital and surgeon volume were also
unavailable. Data on postoperative complications such as periph-
eral and visceral ischaemia, erectile dysfunction and paraplegia
were also not available. While history of stroke and bleeding
disorder prior to surgery were signiﬁcantly associated with post-
operative mortality, the conﬁdence intervals are wide, which is
probably due to the relatively low number of events. While the
generalisability of these ﬁndings may be restricted to hospitals
participating in NSQIP, more than 25% of hospitals across the US
where AAA repairs are performed are enrolled in NSQIP.27 Lastly,
NSQIP does not record outcomes beyond 30 days and so evaluation
of long-term outcomes using these data is not feasible. It would be
ideal to study long-term outcomes; however, given the low numberof patients under 60 years of age undergoing AAA repair, and lack of
multicentre registries with long-term follow-up, this would be
difﬁcult to study.
EVAR has become the approach of choice for the repair of
infrarenal AAAs mainly due to lower perioperative mortality when
compared to open repair. However, this initial advantage is lost
within 2 years of the repair, and long-term data demonstrate that
the rates of graft-related complications, reinterventions and radi-
ation exposure are signiﬁcantly higher with EVAR. The present
study identiﬁes a patient group in which EVAR does not have
a perioperative mortality advantage over open repair. Our data
show that in patients less than 60 years of age, 30-day mortality
after open repair is comparable to that after EVAR, with 30-day
morbidity being higher. Our data can signiﬁcantly aid in the
informed consent process of younger patients with AAA. All
patients should be educated about the advantages and disadvan-
tages of EVAR; some would prefer the upfront morbidity risk of
open surgery to avoid the late consequences of EVAR, while others
would not.
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